CompletedPhase 2

Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients

NCT01097096

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novartis Investigative Site

Costa Mesa, California, United States

+30 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2010-03
Enrollment: 177 participants
Sponsor: Novartis Pharmaceuticals
Purpose: treatment

Locations (31)

Novartis Investigative SiteCosta Mesa, California, United States
Novartis Investigative SiteBoulder, Colorado, United States
Novartis Investigative SiteHollywood, Florida, United States
Novartis Investigative SiteIndianapolis, Indiana, United States
Novartis Investigative SiteEatontown, New Jersey, United States
Novartis Investigative SiteAntwerp, Belgium
Novartis Investigative SiteLeuven, Belgium
Novartis Investigative SiteToronto, Ontario, Canada
Novartis Investigative SiteToronto, Ontario, Canada
Novartis Investigative SiteGreenfield Park, Quebec, Canada
Novartis Investigative SiteMontreal, Quebec, Canada
Novartis Investigative SiteMagdeburg, Germany
Novartis Investigative SiteNuremberg, Germany
Novartis Investigative SiteBrescia, BS, Italy
Novartis Investigative SiteFlorence, FI, Italy
Novartis Investigative SiteGenova, GE, Italy
Novartis Investigative SiteMilan, MI, Italy
Novartis Investigative SiteRoma, RM, Italy
Novartis Investigative SiteRoma, RM, Italy
Novartis Investigative SiteAmsterdam, Netherlands
Novartis Investigative SiteStavanger, Norway
Novartis Investigative SiteSant Cugat del Vallès, Barcelona, Spain
Novartis Investigative SiteBarakaldo, Basque Country, Spain
Novartis Investigative SiteBarcelona, Catalonia, Spain
Novartis Investigative SiteBarcelona, Catalonia, Spain
Novartis Investigative SiteBarcelona, Catalonia, Spain
Novartis Investigative SiteMölndal, Sweden
Novartis Investigative SiteStockholm, Sweden
Novartis Investigative SiteBasel, Switzerland
Novartis Investigative SiteBiel, Switzerland
Novartis Investigative SiteLausanne, Switzerland